Select the Industry/ Sector 👉    All Sectors

Top Healthcare Sector Companies in India by Market Cap

Company
Analysis-Long & Short Term
Industry
Price (EOD)
MarketCap
    Long Term Analysis
Fundamentals : Good
Valuation : Bad [Stock is Expensive]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Neutral
Price Momentum : Downward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹18,761.9
₹39,868 Cr
    Long Term Analysis
Fundamentals : Good
Valuation : Average [Stock is fairly valued]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Downward
Price Momentum : Downward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹2,959.9
₹35,390 Cr
    Long Term Analysis
Fundamentals : Good
Valuation : Bad [Stock is Expensive]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Upward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹1,276.3
₹16,353 Cr
Pharmaceuticals & Drugs
₹652.6
₹12,827 Cr
Pharmaceuticals & Drugs
₹428.9
₹3,971 Cr
Pharmaceuticals & Drugs
₹264.0
₹2,952 Cr
Pharmaceuticals & Drugs
₹71.5
₹1,835 Cr
Pharmaceuticals & Drugs
₹533.3
₹304 Cr
Pharmaceuticals & Drugs
₹29.0
₹222 Cr
Pharmaceuticals & Drugs
₹63.5
₹134 Cr

Top Healthcare Sector Companies in India by Revenues

Company
Analysis-Long & Short Term
Industry
Price (EOD)
Revenues (TTM)
    Long Term Analysis
Fundamentals : Good
Valuation : Average [Stock is fairly valued]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Downward
Price Momentum : Downward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹2,959.9
₹10,479 Cr
    Long Term Analysis
Fundamentals : Good
Valuation : Good [Stock is Cheap]
Debt : Average
  
    Short Term Analysis
Quarterly Earnings Trend : Downward
Price Momentum : Downward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹652.6
₹5,242 Cr
    Long Term Analysis
Fundamentals : Good
Valuation : Bad [Stock is Expensive]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Upward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹1,276.3
₹3,544 Cr
Pharmaceuticals & Drugs
₹428.9
₹2,531 Cr
Pharmaceuticals & Drugs
₹264.0
₹513 Cr
Pharmaceuticals & Drugs
₹29.0
₹198 Cr
Pharmaceuticals & Drugs
₹63.5
₹112 Cr
Pharmaceuticals & Drugs
₹71.5
₹79 Cr
Pharmaceuticals & Drugs
₹533.3
₹326 Cr
Pharmaceuticals & Drugs
₹18,761.9
₹5,006 Cr

Top Healthcare Sector Companies in India by Net Profit

Company
Analysis-Long & Short Term
Industry
Price (EOD)
Net Profit (TTM)
    Long Term Analysis
Fundamentals : Good
Valuation : Average [Stock is fairly valued]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Downward
Price Momentum : Downward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹2,959.9
₹1,332 Cr
    Long Term Analysis
Fundamentals : Good
Valuation : Bad [Stock is Expensive]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Upward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹1,276.3
₹714 Cr
    Long Term Analysis
Fundamentals : Good
Valuation : Good [Stock is Cheap]
Debt : Average
  
    Short Term Analysis
Quarterly Earnings Trend : Downward
Price Momentum : Downward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹652.6
₹309 Cr
Pharmaceuticals & Drugs
₹428.9
₹191 Cr
Pharmaceuticals & Drugs
₹264.0
₹102 Cr
Pharmaceuticals & Drugs
₹71.5
₹86 Cr
Pharmaceuticals & Drugs
₹29.0
₹24 Cr
Pharmaceuticals & Drugs
₹63.5
₹14 Cr
Pharmaceuticals & Drugs
₹533.3
₹27 Cr
Pharmaceuticals & Drugs
₹18,761.9
₹809 Cr

STOCK ANALYSIS Smart-Investing
LEARN VIA VIDEO COURSE Stock Market Investing Simplified- The best Video Course by Smart-Investing.in

You may also like the below Video Courses